Turning insights into medicines

Our mission is to provide the world‘s most advanced platform to unlock chemical matter and help to bring the most innovative medicines to patients. Since the inception of the company, we have successfully pioneered our “structural data first” approach to unlock untapped potential of difficult targets.

drug discovery services

CrystalsFirst provides cutting-edge solutions to unlock chemical matter for protein targets. Our discovery platform and flexible business model have a proven track record of successful campaign with global pharma and biotech companies.

protein production

structural biology

scientific consulting

target-to-lead

what partners say about us

"CrystalsFirst is a recognized expert in crystallographic fragment screening and co-structure determination to unlock chemical matter. The company has always focused on meeting our expectations, taking the time to understand the project and its complexities. We enjoyed collaborating with the CrystalsFirst team and recommend CrystalsFirst’s expertise and services to other companies.”

CrystalsFirst’s platform significantly improved the crystallographic quality and unlocked the potential for a novel inhibition mechanism of our target of interest. Their team is distinguished by flexible problem skills and pro-active communication. We absolutely recommend CrystalsFirst’s expertise and services to other companies!

Previous

Next

Our Alliances

contact us to unlock chemical matter